Misonix Presents at MicroCapClub Invitational

                Misonix Presents at MicroCapClub Invitational

Company Invites Investors to View Presentation

PR Newswire

FARMINGDALE, N.Y., Jan. 31, 2013

FARMINGDALE, N.Y., Jan. 31, 2013 /PRNewswire/ --Misonix, Inc. (NasdaqGM:
MSON), a surgical device company that designs, manufactures and markets
innovative therapeutic ultrasonic products worldwide for spine surgery,
cranial maxillo – facial surgery, neurosurgery,wound debridement, cosmetic
surgery, laparoscopic surgery and other surgical applications, has been
selected to present at the first ever MicroCapClub Invitational, an online
forum featuring unique microcap companies.

The Misonix presentation can be accessed at the following

"At MicroCapClub we have more than 160 experienced microcap investors
highlighting over 90 microcap companies in our members forum. As a group, we
thought it would be instructive to showcase a number companies we believe are
highly unique," said Ian Cassel, founder of MicroCapClub. "We have been
following Misonix since last November, and we believe the company's ultrasonic
surgical devices will continue to gain market share in 2013 and beyond."

"We are pleased to participate in this first ever event," said Michael A.
McManus, Jr., president and chief executive officer of Misonix. "We welcome
the opportunity to introduce Misonix to a universe of potential new

About MicroCapClub:

The MicrocapClub (mc2) is an exclusive microcap forum focused on microcap
companies (sub $300m market cap). The MicroCapClub was created and founded by
Ian Cassel as a way to share ideas and to learn from other seasoned
like-minded microcap investors. Our goal at MicroCapClubis quality membership
and quality stock ideas. If you are an experienced microcap investor, feel
free toApply Today. Go to www.microcapclub.com for additional information.

About Misonix

Misonix, Inc. designs, develops, manufactures and markets therapeutic
ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the
basis for several innovative medical technologies. Addressing a combined
market estimated to be in excess of $3 billion annually; Misonix's proprietary
ultrasonic medical devices are used for wound debridement, cosmetic surgery,
neurosurgery, laparoscopic surgery, and other surgical and medical
applications. Additional information is available on the Company's Web site at

Safe Harbor Statement

With the exception of historical information contained in this press release,
content herein may contain "forward looking statements" that are made pursuant
to the Safe Harbor Provisions of the Private Securities Litigation Reform Act
of 1995. These statements are based on management's current expectations and
are subject to uncertainty and changes in circumstances. Investors are
cautioned that forward-looking statements involve risks and uncertainties that
could cause actual results to differ materially from the statements made.
These factors include general economic conditions, delays and risks associated
with the performance of contracts, risks associated with international sales
and currency fluctuations, uncertainties as a result of research and
development, acceptable results from clinical studies, including publication
of results and patient/procedure data with varying levels of statistical
relevancy, risks involved in introducing and marketing new products, potential
acquisitions, consumer and industry acceptance, litigation and/or court
proceedings, including the timing and monetary requirements of such
activities, the timing of finding strategic partners and implementing such
relationships, regulatory risks including approval of pending and/or
contemplated 510(k) filings, the ability to achieve and maintain profitability
in the Company's business lines, and other factors discussed in the Company's
Annual Report on Form 10-K, subsequent Quarterly Reports on Form 10-Q and
Current Reports on Form 8-K. The Company disclaims any obligation to update
its forward-looking relationships.

                    Investor Relations Contacts
Misonix Contact:  Lytham Partners, LLC
Richard Zaremba   Robert Blum, Joe Dorame, Joe Diaz
631-694-9555       602-889-9700
invest@misonix.com mson@lythampartners.com

SOURCE Misonix, Inc.

Website: http://www.misonix.com
Press spacebar to pause and continue. Press esc to stop.